U.K. approves Sucampo's Amitiza

The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) approved twice-daily Amitiza lubiprostone from Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP) to treat chronic idiopathic constipation...